Valuation: GENFIT

Market Cap 557M 625M 511M 464M 873M 59.11B 893M 6.11B 2.45B 31.28B 2.35B 2.3B 99.11B P/E 2026 *
-42.5x
P/E 2027 * 16.8x
Enterprise Value 615M 690M 564M 513M 964M 65.25B 986M 6.74B 2.7B 34.54B 2.59B 2.54B 109B EV / Sales 2026 *
7.64x
EV / Sales 2027 * 3.98x
Free-Float
86.79%
Yield 2026 *
-
Yield 2027 * -
1 day+0.54%
1 week-2.79%
Current month+2.58%
1 month+22.42%
3 months-22.10%
6 months+36.19%
Current year+111.59%
1 week 10.22
Extreme 10.22
11.72
1 month 7.72
Extreme 7.72
11.72
Current year 5.05
Extreme 5.05
15.48
1 year 3.4
Extreme 3.4
15.48
3 years 2.62
Extreme 2.62
15.48
5 years 2.62
Extreme 2.62
15.48
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 2019-09-15
Director of Finance/CFO 52 2021-04-21
Chief Tech/Sci/R&D Officer - 2025-11-26
Director TitleAgeSince
Chairman 70 2017-06-15
Director/Board Member 58 2017-06-15
Director/Board Member 70 2017-06-15
Date Insider Type Main position Quantity % Market Cap. Importance
3/5/26 Exercice

Chief Operating Officer

11,250 0.0225%
3/5/26 Exercice

Chief Operating Officer

7,083 0.0142%
3/5/26 Sell

Chief Operating Officer

7,083 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+0.54%-2.79%+209.96%+254.78% 620M
+10.00%+4.50%+58.63%+71.20% 60.57B
+1.44%+5.05%+22.52%+101.03% 55.51B
+3.32%+2.31%+11.04%+75.04% 55.22B
+0.46%-5.47%+25.04%+33.77% 43.27B
+6.42%+1.18%+22.18%+105.56% 40.36B
+2.82%+5.82%+240.96%+801.17% 41.63B
-3.79%-7.50%+89.46%+77.13% 33.29B
+5.32%+5.37%+19.12%+52.98% 32.27B
+5.32%+13.43%-39.82%+342.66% 22.91B
Average +3.18%+5.09%+65.91%+191.53% 38.57B
Weighted average by Cap. +3.72%+4.84%+52.47%+169.65%

Financials

2026 *2027 *
Net sales 80.53M 90.37M 73.85M 67.11M 126M 8.54B 129M 883M 354M 4.52B 339M 332M 14.32B 128M 144M 118M 107M 201M 13.61B 206M 1.41B 564M 7.2B 541M 529M 22.82B
Net income -6.42M -7.2M -5.88M -5.35M -10.05M -680M -10.28M -70.31M -28.19M -360M -27.02M -26.44M -1.14B 40.45M 45.39M 37.09M 33.71M 63.37M 4.29B 64.82M 443M 178M 2.27B 170M 167M 7.19B
Net Debt 57.92M 65M 53.12M 48.27M 90.74M 6.14B 92.82M 635M 254M 3.25B 244M 239M 10.3B -46.91M -52.64M -43.02M -39.09M -73.49M -4.97B -75.17M -514M -206M -2.63B -198M -193M -8.34B
Projected Income Statement - Annual - GENFIT
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
180
Date Price Change Volume
26-11-04 €11.14 +0.54% 247,594
26-11-03 €11.08 +6.54% 165,401
26-11-02 €10.40 -4.24% 272,726
26-10-30 €10.86 -4.74% 226,946
26-10-29 €11.40 -0.52% 356,038
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - GENFIT
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.14EUR
Average target price
18.88EUR
Spread / Average Target
+69.48%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - GENFIT
  1. Stock Market
  2. Stocks
  3. GNFT Stock